IQVIA income statement

In fiscal 2025, IQVIA reported revenue of $16.31bn, up 5.9% on the year before, operating income of $2.18bn (a 13.4% margin) and net income of $1.36bn, or $7.84 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

IQVIA: income statement, annual
Fiscal year	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Revenue	4.3	4.9	5.1	5.5	5.7	6.9	9.7	10.4	11.1	11.4	13.9	14.4	15.0	15.4	16.3	17.3
Research and development	0.0	0.0	0.0	0.0	0.0	—	—	—	—	—	—	—	—	—	—	—
Selling, general and administrative	0.8	0.8	0.9	0.8	0.8	1.0	1.6	1.7	1.7	1.8	2.0	2.1	2.1	2.0	2.0	2.1
Operating income	0.3	0.4	0.5	0.6	0.6	0.6	0.7	0.7	0.8	0.7	1.4	1.8	2.0	2.2	2.2	2.2
Interest expense	0.1	−0.1	0.1	0.1	0.1	0.1	0.3	0.4	0.4	0.4	0.4	0.4	0.7	0.7	0.7	0.8
Income before tax	0.2	0.3	0.3	0.5	0.5	0.4	0.3	0.3	0.4	0.4	1.1	1.4	1.5	1.7	1.6	1.6
Income tax	0.0	0.1	0.1	0.1	0.2	0.3	−1.0	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.3
Net income	0.2	0.2	0.2	0.4	0.4	0.1	1.3	0.3	0.2	0.3	1.0	1.1	1.4	1.4	1.4	1.4
Diluted EPS	$2.05	$1.51	$1.77	$2.72	$3.08	$0.47	$5.74	$1.24	$0.96	$1.43	$4.95	$5.72	$7.29	$7.49	$7.84	$8.25
Diluted shares (average)	118m	118m	128m	131m	126m	152m	223m	208m	200m	195m	195m	191m	186m	183m	174m	169m
EBITDA	0.4	0.5	0.6	0.7	0.8	0.9	1.7	1.9	2.0	2.0	2.7	2.9	3.1	3.3	3.3	3.4

US$ millions unless shown otherwise. Fiscal quarters.

IQVIA: income statement, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Revenue	3,958	3,829	4,017	4,100	4,364	4,151	4,368	4,428
Selling, general and administrative	453	508	509	514	468	502	574	569
Operating income	626	496	506	553	627	514	506	572
Interest expense	171	165	182	189	193	192	197	203
Income before tax	544	323	323	408	537	328	301	386
Income tax	112	61	56	76	59	59	60	76
Net income	437	249	266	331	514	274	256	350
Diluted EPS	$2.41	$1.40	$1.54	$1.93	$2.98	$1.61	$1.53	$2.10
EBITDA	929	761	782	839	944	802	798	893

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DHR vs IQV ICLR vs IQV A vs IQV IQV vs TMO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from IQVIA's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to IQVIA.